Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1,Condition 2,Condition 3 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood insulin amount,,RS:0000364,F344/NSlc,male,211 days,7,,CMO:0000358,serum insulin level,,,,0.000222,mg/dl,0.0,1.0E-4,MMO:0000113,oral glucose tolerance test,,0.0,"ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN)",oral glucose,0,min,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",67475,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) " 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood insulin amount,,RS:0001734,F344.OLETF-(D7Mgh16-D7Mgh20)/Tj,male,211 days,7,,CMO:0000358,serum insulin level,,,,0.000213,mg/dl,0.0,1.0E-4,MMO:0000113,oral glucose tolerance test,,0.0,"ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN)",oral glucose,0,min,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",67476,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) " 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood insulin amount,,RS:0000289,F344.OLETF-(D14Rat23-D14Rat12)/Tj,male,211 days,11,,CMO:0000358,serum insulin level,,,,0.000316,mg/dl,0.0,1.0E-4,MMO:0000113,oral glucose tolerance test,,0.0,"ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN)",oral glucose,0,min,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",67477,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) " 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood insulin amount,,RS:0001303,F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj,male,211 days,11,,CMO:0000358,serum insulin level,,,,0.000339,mg/dl,0.0,1.0E-4,MMO:0000113,oral glucose tolerance test,,0.0,"ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN)",oral glucose,0,min,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",67478,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) " 85,"Galli J, et al., Diabetes 1999 Dec;48(12):2463-70.",blood insulin amount,,RS:0000280,F344.GK-(D1Arb42a-D1Rat90)/Swe,male,65 days,11,,CMO:0000358,serum insulin level,,,,0.003596,mg/dl,0.001,0.0035,MMO:0000164,intraperitoneal glucose tolerance test,tail vein,0.0,,post glucose injection,0,min,fasting (between 6 and 7 hours) then glucose solution (2 g/kg) ,67622,fasting (between 6 and 7 hours),glucose solution (2 g/kg) , 85,"Galli J, et al., Diabetes 1999 Dec;48(12):2463-70.",blood insulin amount,,RS:0000305,F344/DuCrlCrlj,male,65 days,15,,CMO:0000358,serum insulin level,,,,0.004466,mg/dl,4.0E-4,0.0016,MMO:0000164,intraperitoneal glucose tolerance test,tail vein,0.0,,post glucose injection,0,min,fasting (between 6 and 7 hours) then glucose solution (2 g/kg) ,67623,fasting (between 6 and 7 hours),glucose solution (2 g/kg) , 85,"Galli J, et al., Diabetes 1999 Dec;48(12):2463-70.",blood insulin amount,,RS:0000281,F344.GK-(D1Mgh10-D1Rat119)/Swe,male,65 days,11,,CMO:0000358,serum insulin level,,,,0.007076,mg/dl,0.0013,0.0042,MMO:0000164,intraperitoneal glucose tolerance test,tail vein,0.0,,post glucose injection,0,min,fasting (between 6 and 7 hours) then glucose solution (2 g/kg) ,67624,fasting (between 6 and 7 hours),glucose solution (2 g/kg) , 85,"Galli J, et al., Diabetes 1999 Dec;48(12):2463-70.",blood insulin amount,,RS:0000305,F344/DuCrlCrlj,male,65 days,15,,CMO:0000358,serum insulin level,,,,0.071572,mg/dl,0.0106,0.0409,MMO:0000164,intraperitoneal glucose tolerance test,tail vein,0.0,,post glucose injection,15,min,fasting (between 6 and 7 hours) then glucose solution (2 g/kg) ,67625,fasting (between 6 and 7 hours),glucose solution (2 g/kg) , 85,"Galli J, et al., Diabetes 1999 Dec;48(12):2463-70.",blood insulin amount,,RS:0000280,F344.GK-(D1Arb42a-D1Rat90)/Swe,male,65 days,11,,CMO:0000358,serum insulin level,,,,0.031436,mg/dl,0.0044,0.0146,MMO:0000164,intraperitoneal glucose tolerance test,tail vein,0.0,,post glucose injection,15,min,fasting (between 6 and 7 hours) then glucose solution (2 g/kg) ,67626,fasting (between 6 and 7 hours),glucose solution (2 g/kg) , 85,"Galli J, et al., Diabetes 1999 Dec;48(12):2463-70.",blood insulin amount,,RS:0000281,F344.GK-(D1Mgh10-D1Rat119)/Swe,male,65 days,11,,CMO:0000358,serum insulin level,,,,0.073254,mg/dl,0.0083,0.0275,MMO:0000164,intraperitoneal glucose tolerance test,tail vein,0.0,,post glucose injection,15,min,fasting (between 6 and 7 hours) then glucose solution (2 g/kg) ,67627,fasting (between 6 and 7 hours),glucose solution (2 g/kg) , 85,"Galli J, et al., Diabetes 1999 Dec;48(12):2463-70.",blood insulin amount,,RS:0000305,F344/DuCrlCrlj,male,65 days,15,,CMO:0000358,serum insulin level,,,,0.028884,mg/dl,0.0039,0.0153,MMO:0000164,intraperitoneal glucose tolerance test,tail vein,0.0,,post glucose injection,30,min,fasting (between 6 and 7 hours) then glucose solution (2 g/kg) ,67628,fasting (between 6 and 7 hours),glucose solution (2 g/kg) , 85,"Galli J, et al., Diabetes 1999 Dec;48(12):2463-70.",blood insulin amount,,RS:0000280,F344.GK-(D1Arb42a-D1Rat90)/Swe,male,65 days,11,,CMO:0000358,serum insulin level,,,,0.023084,mg/dl,0.0039,0.0131,MMO:0000164,intraperitoneal glucose tolerance test,tail vein,0.0,,post glucose injection,30,min,fasting (between 6 and 7 hours) then glucose solution (2 g/kg) ,67629,fasting (between 6 and 7 hours),glucose solution (2 g/kg) , 85,"Galli J, et al., Diabetes 1999 Dec;48(12):2463-70.",blood insulin amount,,RS:0000281,F344.GK-(D1Mgh10-D1Rat119)/Swe,male,65 days,11,,CMO:0000358,serum insulin level,,,,0.05684,mg/dl,0.0089,0.0294,MMO:0000164,intraperitoneal glucose tolerance test,tail vein,0.0,,post glucose injection,30,min,fasting (between 6 and 7 hours) then glucose solution (2 g/kg) ,67630,fasting (between 6 and 7 hours),glucose solution (2 g/kg) , 85,"Galli J, et al., Diabetes 1999 Dec;48(12):2463-70.",blood insulin amount,,RS:0000280,F344.GK-(D1Arb42a-D1Rat90)/Swe,male,95 days,11,,CMO:0000358,serum insulin level,,,,0.01305,mg/dl,0.0028,0.0092,MMO:0000164,intraperitoneal glucose tolerance test,tail vein,0.0,,post glucose injection,0,min,fasting (between 6 and 7 hours) then glucose solution (2 g/kg) ,67631,fasting (between 6 and 7 hours),glucose solution (2 g/kg) , 85,"Galli J, et al., Diabetes 1999 Dec;48(12):2463-70.",blood insulin amount,,RS:0000305,F344/DuCrlCrlj,male,95 days,15,,CMO:0000358,serum insulin level,,,,0.01218,mg/dl,0.0016,0.0061,MMO:0000164,intraperitoneal glucose tolerance test,tail vein,0.0,,post glucose injection,0,min,fasting (between 6 and 7 hours) then glucose solution (2 g/kg) ,67632,fasting (between 6 and 7 hours),glucose solution (2 g/kg) , 85,"Galli J, et al., Diabetes 1999 Dec;48(12):2463-70.",blood insulin amount,,RS:0000281,F344.GK-(D1Mgh10-D1Rat119)/Swe,male,95 days,11,,CMO:0000358,serum insulin level,,,,0.013804,mg/dl,0.0046,0.0154,MMO:0000164,intraperitoneal glucose tolerance test,tail vein,0.0,,post glucose injection,0,min,fasting (between 6 and 7 hours) then glucose solution (2 g/kg) ,67633,fasting (between 6 and 7 hours),glucose solution (2 g/kg) , 85,"Galli J, et al., Diabetes 1999 Dec;48(12):2463-70.",blood insulin amount,,RS:0000305,F344/DuCrlCrlj,male,95 days,15,,CMO:0000358,serum insulin level,,,,0.08265,mg/dl,0.0119,0.046,MMO:0000164,intraperitoneal glucose tolerance test,tail vein,0.0,,post glucose injection,15,min,fasting (between 6 and 7 hours) then glucose solution (2 g/kg) ,67634,fasting (between 6 and 7 hours),glucose solution (2 g/kg) , 85,"Galli J, et al., Diabetes 1999 Dec;48(12):2463-70.",blood insulin amount,,RS:0000280,F344.GK-(D1Arb42a-D1Rat90)/Swe,male,95 days,11,,CMO:0000358,serum insulin level,,,,0.04698,mg/dl,0.0112,0.0371,MMO:0000164,intraperitoneal glucose tolerance test,tail vein,0.0,,post glucose injection,15,min,fasting (between 6 and 7 hours) then glucose solution (2 g/kg) ,67635,fasting (between 6 and 7 hours),glucose solution (2 g/kg) , 85,"Galli J, et al., Diabetes 1999 Dec;48(12):2463-70.",blood insulin amount,,RS:0000281,F344.GK-(D1Mgh10-D1Rat119)/Swe,male,95 days,11,,CMO:0000358,serum insulin level,,,,0.067628,mg/dl,0.0166,0.0552,MMO:0000164,intraperitoneal glucose tolerance test,tail vein,0.0,,post glucose injection,15,min,fasting (between 6 and 7 hours) then glucose solution (2 g/kg) ,67636,fasting (between 6 and 7 hours),glucose solution (2 g/kg) , 85,"Galli J, et al., Diabetes 1999 Dec;48(12):2463-70.",blood insulin amount,,RS:0000305,F344/DuCrlCrlj,male,95 days,15,,CMO:0000358,serum insulin level,,,,0.0696,mg/dl,0.0108,0.0418,MMO:0000164,intraperitoneal glucose tolerance test,tail vein,0.0,,post glucose injection,30,min,fasting (between 6 and 7 hours) then glucose solution (2 g/kg) ,67637,fasting (between 6 and 7 hours),glucose solution (2 g/kg) , 85,"Galli J, et al., Diabetes 1999 Dec;48(12):2463-70.",blood insulin amount,,RS:0000280,F344.GK-(D1Arb42a-D1Rat90)/Swe,male,95 days,11,,CMO:0000358,serum insulin level,,,,0.045936,mg/dl,0.011,0.0364,MMO:0000164,intraperitoneal glucose tolerance test,tail vein,0.0,,post glucose injection,30,min,fasting (between 6 and 7 hours) then glucose solution (2 g/kg) ,67638,fasting (between 6 and 7 hours),glucose solution (2 g/kg) , 85,"Galli J, et al., Diabetes 1999 Dec;48(12):2463-70.",blood insulin amount,,RS:0000281,F344.GK-(D1Mgh10-D1Rat119)/Swe,male,95 days,11,,CMO:0000358,serum insulin level,,,,0.066178,mg/dl,0.0172,0.0571,MMO:0000164,intraperitoneal glucose tolerance test,tail vein,0.0,,post glucose injection,30,min,fasting (between 6 and 7 hours) then glucose solution (2 g/kg) ,67640,fasting (between 6 and 7 hours),glucose solution (2 g/kg) , 85,"Galli J, et al., Diabetes 1999 Dec;48(12):2463-70.",blood insulin amount,,RS:0000305,F344/DuCrlCrlj,male,185 days,9,,CMO:0000358,serum insulin level,,,,0.021924,mg/dl,0.0041,0.0124,MMO:0000075,enzyme linked immunosorbent assay,tail vein,0.0,,,,min,fasting (between 6 and 7 hours),67644,fasting (between 6 and 7 hours),, 85,"Galli J, et al., Diabetes 1999 Dec;48(12):2463-70.",blood insulin amount,,RS:0000280,F344.GK-(D1Arb42a-D1Rat90)/Swe,male,185 days,10,,CMO:0000358,serum insulin level,,,,0.027376,mg/dl,0.0029,0.0092,MMO:0000075,enzyme linked immunosorbent assay,tail vein,0.0,,,,min,fasting (between 6 and 7 hours),67645,fasting (between 6 and 7 hours),, 85,"Galli J, et al., Diabetes 1999 Dec;48(12):2463-70.",blood insulin amount,,RS:0000281,F344.GK-(D1Mgh10-D1Rat119)/Swe,male,185 days,10,,CMO:0000358,serum insulin level,,,,0.036598,mg/dl,0.0022,0.007,MMO:0000075,enzyme linked immunosorbent assay,tail vein,0.0,,,,min,fasting (between 6 and 7 hours),67646,fasting (between 6 and 7 hours),, 85,"Galli J, et al., Diabetes 1999 Dec;48(12):2463-70.",blood insulin amount,,RS:0000305,F344/DuCrlCrlj,male,95 days,20,,CMO:0000358,serum insulin level,,,,0.003654,mg/dl,,,MMO:0000164,intraperitoneal glucose tolerance test,tail vein,0.0,,post glucose injection,0,min,fasting (between 6 and 7 hours) then glucose solution (2 g/kg) ,67656,fasting (between 6 and 7 hours),glucose solution (2 g/kg) , 85,"Galli J, et al., Diabetes 1999 Dec;48(12):2463-70.",blood insulin amount,,RS:0000305,F344/DuCrlCrlj,male,95 days,20,,CMO:0000358,serum insulin level,,,,0.0116,mg/dl,,,MMO:0000164,intraperitoneal glucose tolerance test,tail vein,0.0,,post glucose injection,15,min,fasting (between 6 and 7 hours) then glucose solution (2 g/kg) ,67657,fasting (between 6 and 7 hours),glucose solution (2 g/kg) , 85,"Galli J, et al., Diabetes 1999 Dec;48(12):2463-70.",blood insulin amount,,RS:0000305,F344/DuCrlCrlj,male,95 days,20,,CMO:0000358,serum insulin level,,,,0.01247,mg/dl,,,MMO:0000164,intraperitoneal glucose tolerance test,tail vein,0.0,,post glucose injection,30,min,fasting (between 6 and 7 hours) then glucose solution (2 g/kg) ,67658,fasting (between 6 and 7 hours),glucose solution (2 g/kg) , 321,"Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9.",blood insulin amount,,RS:0000976,WBN/KobSlc,male,120 days,5,,CMO:0000358,serum insulin level,,serum glucose,,0.000228,mg/dl,0.0,0.0,MMO:0000113,oral glucose tolerance test,,,,glucose challenge,0,min,controlled protein content diet (for 120 days) then fasting (for 9 hours),12900,controlled protein content diet (for 120 days),fasting (for 9 hours), 321,"Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9.",blood insulin amount,,RS:0000976,WBN/KobSlc,male,120 days,5,,CMO:0000358,serum insulin level,,serum glucose,,0.000452,mg/dl,0.0,1.0E-4,MMO:0000113,oral glucose tolerance test,,,glucose dose not specified,glucose challenge,30,min,controlled protein content diet (for 120 days) then fasting (for 9 hours) then glucose solution,12904,controlled protein content diet (for 120 days),fasting (for 9 hours),glucose solution 321,"Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9.",blood insulin amount,,RS:0000133,BN/CrlCrlj,male,120 days,5,,CMO:0000358,serum insulin level,,serum glucose,,0.000191,mg/dl,0.0,0.0,MMO:0000113,oral glucose tolerance test,,,,glucose challenge,0,min,controlled protein content diet (for 120 days) then fasting (for 9 hours),12911,controlled protein content diet (for 120 days),fasting (for 9 hours), 321,"Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9.",blood insulin amount,,RS:0000133,BN/CrlCrlj,male,120 days,5,,CMO:0000358,serum insulin level,,serum glucose,,0.000195,mg/dl,1.0E-4,1.0E-4,MMO:0000113,oral glucose tolerance test,,,glucose dose not specified,glucose challenge,30,min,controlled protein content diet (for 120 days) then fasting (for 9 hours) then glucose solution,12912,controlled protein content diet (for 120 days),fasting (for 9 hours),glucose solution 324,"Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405.",blood insulin amount,,RS:0000372,BB.SHR-(D6Rat184-D6Rat3)/K,both,84 days,46,,CMO:0000358,serum insulin level,,ng/ml is unit,,0.000058,mg/dl,0.0,0.0,MMO:0000075,enzyme linked immunosorbent assay,opthalmic venous plexus,0.0,,,,,control condition,12981,control condition,, 324,"Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405.",blood insulin amount,,RS:0000372,BB.SHR-(D6Rat184-D6Rat3)/K,both,84 days,32,,CMO:0000358,serum insulin level,,ng/ml is unit,,0.000062,mg/dl,0.0,0.0,MMO:0000075,enzyme linked immunosorbent assay,opthalmic venous plexus,0.0,,,,,control condition,70099,control condition,, 324,"Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405.",blood insulin amount,,RS:0000069,BB.SHR-(Gnal-D18Mit9)/K,both,84 days,25,,CMO:0000358,serum insulin level,,ng/ml is unit,,0.00005,mg/dl,0.0,0.0,MMO:0000075,enzyme linked immunosorbent assay,opthalmic venous plexus,0.0,,,,,control condition,70100,control condition,, 227,"Kloting N, et al., Obes Res 2005 Mar;13(3):589-95.",blood insulin amount,,RS:0000066,BB.WOKW-(D4Got41-Fabp1)/K,male,224 days,16,,CMO:0000358,serum insulin level,,ng/ml,,0.000174,mg/dl,0.0,1.0E-4,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,control condition,11942,control condition,, 227,"Kloting N, et al., Obes Res 2005 Mar;13(3):589-95.",blood insulin amount,,RS:0000063,BB.SHR-(D4Got41-Tacr1)/K,male,224 days,20,,CMO:0000358,serum insulin level,,ng/ml,,0.000071,mg/dl,0.0,0.0,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,control condition,11938,control condition,, 227,"Kloting N, et al., Obes Res 2005 Mar;13(3):589-95.",blood insulin amount,,RS:0000067,BB/OK,male,224 days,20,,CMO:0000358,serum insulin level,,ng/ml,,0.000083,mg/dl,0.0,0.0,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,control condition,67939,control condition,, 251,"Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6.",blood insulin amount,,RS:0000065,WOKW,female,224 days to 196 days,12,,CMO:0000358,serum insulin level,,"average of measures taken at 196 days, 210 days and 224 days",serial mean,0.00022,mg/dl,,,MMO:0000073,radioimmunoassay,ophthalmic venous plexus,0.0,"Roche Cobas Mira Plus (Roche, Switzerland)",,,,control condition,67919,control condition,, 251,"Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6.",blood insulin amount,,RS:0000243,DA/K,female,224 days to 196 days,12,,CMO:0000358,serum insulin level,,"average of measures taken at 196 days, 210 days and 224 days",serial mean,0.00012,mg/dl,,,MMO:0000073,radioimmunoassay,ophthalmic venous plexus,0.0,"Roche Cobas Mira Plus (Roche, Switzerland)",,,,control condition,67920,control condition,, 716,"Kose H, et al., Exp Anim. 2008 Apr;57(2):135-8.",blood insulin amount,,RS:0000364,F344/NSlc,male,210 days,9,,CMO:0000358,serum insulin level,,,,0.000301,mg/dl,0.0,1.0E-4,MMO:0000113,oral glucose tolerance test,,0,,gastric gavage,0,min,"fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) ",66176,fasting (between 16 and 18 hours),"glucose solution, 2.8M (2 g/kg) ", 716,"Kose H, et al., Exp Anim. 2008 Apr;57(2):135-8.",blood insulin amount,,RS:0000296,F344.OLETF-(D8Rat58-D8Mgh17)/Tj,male,210 days,20,,CMO:0000358,serum insulin level,,,,0.000408,mg/dl,0.0,2.0E-4,MMO:0000113,oral glucose tolerance test,,0,,gastric gavage,0,min,"fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) ",66177,fasting (between 16 and 18 hours),"glucose solution, 2.8M (2 g/kg) ", 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood insulin amount,,RS:0000126,PD/Cub,male,300 days,6,,CMO:0000358,serum insulin level,,,,0.01334,mg/dl,5.0E-4,0.0012,MMO:0000073,radioimmunoassay,retroorbital plexus,0.0,,,,,fasting (for 16 hours),70274,fasting (for 16 hours),, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood insulin amount,,RS:0000136,BN/Cub,male,300 days,6,,CMO:0000358,serum insulin level,,,,0.00638,mg/dl,9.0E-4,0.0023,MMO:0000073,radioimmunoassay,retroorbital plexus,0.0,,,,,fasting (for 16 hours),70275,fasting (for 16 hours),, 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood insulin amount,,RS:0000126,PD/Cub,male,307 days,6,,CMO:0000358,serum insulin level,,,,0.01218,mg/dl,0.0017,0.0041,MMO:0000073,radioimmunoassay,retroorbital plexus,0.0,,,,,controlled sucrose content diet (for 7 days) then fasting (for 16 hours),70276,controlled sucrose content diet (for 7 days),fasting (for 16 hours), 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood insulin amount,,RS:0000136,BN/Cub,male,307 days,6,,CMO:0000358,serum insulin level,,,,0.00986,mg/dl,5.0E-4,0.0012,MMO:0000073,radioimmunoassay,retroorbital plexus,0.0,,,,,controlled sucrose content diet (for 7 days) then fasting (for 16 hours),70277,controlled sucrose content diet (for 7 days),fasting (for 16 hours), 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood insulin amount,,RS:0000126,PD/Cub,male,310 days,6,,CMO:0000358,serum insulin level,,,,0.116,mg/dl,0.0047,0.0116,MMO:0000073,radioimmunoassay,retroorbital plexus,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours),70278,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),fasting (for 16 hours) 1318,"Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22.",blood insulin amount,,RS:0000136,BN/Cub,male,310 days,6,,CMO:0000358,serum insulin level,,,,0.0783,mg/dl,0.0166,0.0406,MMO:0000073,radioimmunoassay,retroorbital plexus,0.0,,,,,controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours),70279,controlled sucrose content diet (for 7 days),dexamethasone (0.03 mg/ml) (for 3 days),fasting (for 16 hours) 1123,"Kovacs P, et al., Biochem Biophys Res Commun 2000 Mar 24;269(3):660-5.",blood insulin amount,,RS:0001087,WOKW/K,not specified,224 days to 196 days,12,,CMO:0000358,serum insulin level,,,,0.000424,mg/dl,1.0E-4,2.0E-4,MMO:0000073,radioimmunoassay,,0.0,,,,,control condition,96846,control condition,, 1123,"Kovacs P, et al., Biochem Biophys Res Commun 2000 Mar 24;269(3):660-5.",blood insulin amount,,RS:0000243,DA/K,not specified,224 days to 196 days,12,,CMO:0000358,serum insulin level,,,,0.000147,mg/dl,0.0,1.0E-4,MMO:0000073,radioimmunoassay,,0.0,,,,,control condition,96847,control condition,, 2644,"Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4.",blood insulin amount,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,91 days,6,,CMO:0000358,serum insulin level,,,,0.000807,mg/dl,1.0E-4,2.0E-4,MMO:0000322,serum insulin analysis,,0.0,,,,,vehicle control condition (0.5 %) (for 28 days),101959,vehicle control condition (0.5 %) (for 28 days),, 2644,"Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4.",blood insulin amount,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,91 days,7,,CMO:0000358,serum insulin level,,,,0.000429,mg/dl,1.0E-4,4.0E-4,MMO:0000322,serum insulin analysis,,0.0,,,,,Atorvastatin (6 mg/kg/d) (for 28 days),101960,Atorvastatin (6 mg/kg/d) (for 28 days),, 2644,"Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4.",blood insulin amount,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,91 days,7,,CMO:0000358,serum insulin level,,,,0.000434,mg/dl,2.0E-4,4.0E-4,MMO:0000322,serum insulin analysis,,0.0,,,,,Atorvastatin (20 mg/kg/d) (for 28 days),101961,Atorvastatin (20 mg/kg/d) (for 28 days),, 2884,"Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7.",blood insulin amount,,RS:0004409,Jcl:WI,male,52 days,6,,CMO:0000358,serum insulin level,,,,0.000163,mg/dl,1.0E-4,4.0E-4,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,control condition,103936,control condition,, 2884,"Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7.",blood insulin amount,,RS:0004580,GK/Jcl,male,52 days,6,,CMO:0000358,serum insulin level,,,,0.000546,mg/dl,3.0E-4,6.0E-4,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,control condition,103937,control condition,, 2884,"Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7.",blood insulin amount,,RS:0004580,GK/Jcl,male,52 days,6,,CMO:0000358,serum insulin level,,,,0.000066,mg/dl,0.0,1.0E-4,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,controlled hesperidin content diet (1 %) (for 28 days),103938,controlled hesperidin content diet (1 %) (for 28 days),, 2884,"Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7.",blood insulin amount,,RS:0004580,GK/Jcl,male,52 days,6,,CMO:0000358,serum insulin level,,,,0.00012,mg/dl,1.0E-4,3.0E-4,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,controlled cyclodextrin (CD)-clathrated hesperetin content diet (4.6 %) (for 28 days),103939,controlled cyclodextrin (CD)-clathrated hesperetin content diet (4.6 %) (for 28 days),, 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",blood insulin amount,,RS:0004552,SS.ZUC-Leprfa+/+/Slc,male,126 days,6,,CMO:0000358,serum insulin level,,,,0.000055,mg/dl,0.0,1.0E-4,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,fasting (for 16 hours),101915,fasting (for 16 hours),, 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",blood insulin amount,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,126 days,7,,CMO:0000358,serum insulin level,,,,0.000318,mg/dl,1.0E-4,4.0E-4,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,fasting (for 16 hours),101916,fasting (for 16 hours),, 2783,"Korkmaz-Ic?z S, et al., Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12.",blood insulin amount,,RS:0001011,Crl:WI,male,112 days,10,,CMO:0000358,serum insulin level,,,,0.000076,mg/dl,0.0,0.0,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,control condition,102942,control condition,, 2783,"Korkmaz-Ic?z S, et al., Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12.",blood insulin amount,,RS:0001317,GK/MolTac,male,112 days,8,,CMO:0000358,serum insulin level,,,,0.000148,mg/dl,0.0,1.0E-4,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,control condition,102943,control condition,, 2969,"Vaira S, et al., Endocrinology. 2012 Nov;153(11):5622-8. doi: 10.1210/en.2012-1462. Epub 2012 Sep 4.",blood insulin amount,,RS:0001410,NTac:SD,not specified,28 days,10,,CMO:0000358,serum insulin level,,,,0.0000035,mg/dl,0.0,0.0,MMO:0000322,serum insulin analysis,,0.0,,,,,fasting (for 16 hours),104535,fasting (for 16 hours),, 2969,"Vaira S, et al., Endocrinology. 2012 Nov;153(11):5622-8. doi: 10.1210/en.2012-1462. Epub 2012 Sep 4.",blood insulin amount,,RS:0004449,SD-Lepem1Sage-/-,not specified,28 days,10,,CMO:0000358,serum insulin level,,,,0.0000855,mg/dl,0.0,1.0E-4,MMO:0000322,serum insulin analysis,,0.0,,,,,fasting (for 16 hours),104536,fasting (for 16 hours),, 3071,"Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19.",blood insulin amount,"fasting insulin, non fasting insulin",RS:0001317,GK/MolTac,female,60 days,6,,CMO:0000358,serum insulin level,,,,0.000149,mg/dl,0.0,0.0,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,control condition,106917,control condition,, 3071,"Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19.",blood insulin amount,"fasting insulin, non fasting insulin",RS:0001317,GK/MolTac,female,240 days,11,,CMO:0000358,serum insulin level,,,,0.000042,mg/dl,0.0,0.0,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,control condition,106918,control condition,, 3071,"Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19.",blood insulin amount,"fasting insulin, non fasting insulin",RS:0001317,GK/MolTac,female,420 days,11,,CMO:0000358,serum insulin level,,,,0.00002,mg/dl,0.0,0.0,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,control condition,106919,control condition,, 3071,"Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19.",blood insulin amount,"fasting insulin, non fasting insulin",RS:0001602,WKY/NMolTac,female,60 days,6,,CMO:0000358,serum insulin level,,,,0.0003,mg/dl,1.0E-4,2.0E-4,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,control condition,106920,control condition,, 3071,"Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19.",blood insulin amount,"fasting insulin, non fasting insulin",RS:0001602,WKY/NMolTac,female,240 days,9,,CMO:0000358,serum insulin level,,,,0.000064,mg/dl,0.0,1.0E-4,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,control condition,106921,control condition,, 3071,"Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19.",blood insulin amount,"fasting insulin, non fasting insulin",RS:0001602,WKY/NMolTac,female,420 days,9,,CMO:0000358,serum insulin level,,,,0.00005,mg/dl,0.0,1.0E-4,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,control condition,106922,control condition,, 3071,"Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19.",blood insulin amount,"fasting insulin, non fasting insulin",RS:0001317,GK/MolTac,female,60 days,6,,CMO:0000358,serum insulin level,,,,0.000047,mg/dl,0.0,0.0,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,fasting (for 6 hours),106923,fasting (for 6 hours),, 3071,"Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19.",blood insulin amount,"fasting insulin, non fasting insulin",RS:0001317,GK/MolTac,female,240 days,11,,CMO:0000358,serum insulin level,,,,0.000064,mg/dl,0.0,0.0,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,fasting (for 6 hours),106924,fasting (for 6 hours),, 3071,"Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19.",blood insulin amount,"fasting insulin, non fasting insulin",RS:0001317,GK/MolTac,female,420 days,11,,CMO:0000358,serum insulin level,,,,0.000034,mg/dl,0.0,0.0,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,fasting (for 6 hours),106925,fasting (for 6 hours),, 3071,"Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19.",blood insulin amount,"fasting insulin, non fasting insulin",RS:0001602,WKY/NMolTac,female,60 days,6,,CMO:0000358,serum insulin level,,,,0.000072,mg/dl,0.0,0.0,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,fasting (for 6 hours),106926,fasting (for 6 hours),, 3071,"Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19.",blood insulin amount,"fasting insulin, non fasting insulin",RS:0001602,WKY/NMolTac,female,240 days,9,,CMO:0000358,serum insulin level,,,,0.000009,mg/dl,0.0,0.0,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,fasting (for 6 hours),106927,fasting (for 6 hours),, 3071,"Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19.",blood insulin amount,"fasting insulin, non fasting insulin",RS:0001602,WKY/NMolTac,female,420 days,9,,CMO:0000358,serum insulin level,,,,0.000027,mg/dl,0.0,0.0,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,fasting (for 6 hours),106928,fasting (for 6 hours),, 3167,"Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5.",blood insulin amount,,RS:0004409,Jcl:WI,male,154 days,7,,CMO:0000358,serum insulin level,,,,0.00011,mg/dl,0.0,0.0,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,fasting,110213,fasting,, 3167,"Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5.",blood insulin amount,,RS:0004409,Jcl:WI,male,154 days,7,,CMO:0000358,serum insulin level,,,,0.0001,mg/dl,0.0,1.0E-4,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,vildagliptin (30 mg/kg/d) (for 106 days) then fasting,110214,vildagliptin (30 mg/kg/d) (for 106 days),fasting, 3167,"Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5.",blood insulin amount,,RS:0004580,GK/Jcl,male,154 days,7,,CMO:0000358,serum insulin level,,,,0.00013,mg/dl,0.0,1.0E-4,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,fasting,110215,fasting,, 3167,"Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5.",blood insulin amount,,RS:0001299,GK,male,154 days,7,,CMO:0000358,serum insulin level,,,,0.00012,mg/dl,0.0,1.0E-4,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,vildagliptin (30 mg/kg/d) (for 106 days) then fasting,110216,vildagliptin (30 mg/kg/d) (for 106 days),fasting, 3167,"Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5.",blood insulin amount,,RS:0004409,Jcl:WI,male,140 days,7,,CMO:0000358,serum insulin level,,,,0.00033,mg/dl,0.0,1.0E-4,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,glucose,30,min,fasting then glucose solution (2 g/kg) (for 0.5 hours),110217,fasting,glucose solution (2 g/kg) (for 0.5 hours), 3167,"Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5.",blood insulin amount,,RS:0004409,Jcl:WI,male,140 days,7,,CMO:0000358,serum insulin level,,,,0.00034,mg/dl,0.0,1.0E-4,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,glucose,30,min,vildagliptin (30 mg/kg/d) (for 92 days) then fasting then glucose solution (2 g/kg) (for 0.5 hours),110218,vildagliptin (30 mg/kg/d) (for 92 days),fasting,glucose solution (2 g/kg) (for 0.5 hours) 3167,"Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5.",blood insulin amount,,RS:0004580,GK/Jcl,male,140 days,7,,CMO:0000358,serum insulin level,,,,0.00018,mg/dl,0.0,1.0E-4,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,glucose,30,min,fasting then glucose solution (2 g/kg) (for 0.5 hours),110219,fasting,glucose solution (2 g/kg) (for 0.5 hours), 3167,"Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5.",blood insulin amount,,RS:0004409,Jcl:WI,male,140 days,7,,CMO:0000358,serum insulin level,,,,0.00027,mg/dl,1.0E-4,2.0E-4,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,glucose,30,min,vildagliptin (30 mg/kg/d) (for 92 days) then fasting then glucose solution (2 g/kg) (for 0.5 hours),110220,vildagliptin (30 mg/kg/d) (for 92 days),fasting,glucose solution (2 g/kg) (for 0.5 hours) 3168,"Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027.",blood insulin amount,,RS:0001592,HanTac:WH,female,98 days,8,,CMO:0000358,serum insulin level,,,,0.000257,mg/dl,0.0,1.0E-4,MMO:0000322,serum insulin analysis,,0.0,,,,,control IgG monoclonal antibody (1 mg) (for 42 days),110277,control IgG monoclonal antibody (1 mg) (for 42 days),, 3168,"Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027.",blood insulin amount,,RS:0001592,HanTac:WH,female,98 days,8,,CMO:0000358,serum insulin level,,,,0.000168,mg/dl,0.0,1.0E-4,MMO:0000322,serum insulin analysis,,0.0,,,,,anti-rh-VEGF165 monoclonal antibody (1 mg) (for 42 days),110278,anti-rh-VEGF165 monoclonal antibody (1 mg) (for 42 days),, 3168,"Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027.",blood insulin amount,,RS:0001317,GK/MolTac,female,98 days,9,,CMO:0000358,serum insulin level,,,,0.000295,mg/dl,1.0E-4,3.0E-4,MMO:0000322,serum insulin analysis,,0.0,,,,,control IgG monoclonal antibody (1 mg) (for 42 days),110279,control IgG monoclonal antibody (1 mg) (for 42 days),, 3168,"Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027.",blood insulin amount,,RS:0001317,GK/MolTac,female,98 days,10,,CMO:0000358,serum insulin level,,,,0.000172,mg/dl,0.0,1.0E-4,MMO:0000322,serum insulin analysis,,0.0,,,,,anti-rh-VEGF165 monoclonal antibody (1 mg) (for 42 days),110280,anti-rh-VEGF165 monoclonal antibody (1 mg) (for 42 days),, 3185,"Ohta T, et al., Br J Pharmacol. 1999 Apr;126(7):1674-80. doi: 10.1038/sj.bjp.0702481.",blood insulin amount,,RS:0001840,Crlj:WI,male,56 days,5,,CMO:0000358,serum insulin level,,,,0.0030218,mg/dl,1.0E-4,3.0E-4,MMO:0000073,radioimmunoassay,,0.0,,,,,fasting (for 16 hours),110770,fasting (for 16 hours),, 3185,"Ohta T, et al., Br J Pharmacol. 1999 Apr;126(7):1674-80. doi: 10.1038/sj.bjp.0702481.",blood insulin amount,,RS:0004817,GK/CskCrlj,male,56 days,5,,CMO:0000358,serum insulin level,,,,0.0076444,mg/dl,0.0022,0.005,MMO:0000073,radioimmunoassay,,0.0,,,,,fasting (for 16 hours),110771,fasting (for 16 hours),,